| Malaria |
2.17 |
0.00e+0 |
44/50 (88%) |
CXCL8;HBB;COMP;...
|
| Allograft rejection |
2.12 |
0.00e+0 |
32/38 (84.21%) |
HLA-DRB1;HLA-DRA;HLA-B;...
|
| NF-kappa B signaling pathway |
2.09 |
0.00e+0 |
90/104 (86.54%) |
CXCL8;CXCL2;TNFAIP3;...
|
| Graft-versus-host disease |
2.08 |
0.00e+0 |
32/42 (76.19%) |
HLA-DRB1;HLA-DRA;HLA-B;...
|
| Legionellosis |
2.05 |
0.00e+0 |
51/57 (89.47%) |
HSPA1A;CXCL8;CXCL2;...
|
| Th17 cell differentiation |
2.05 |
0.00e+0 |
95/107 (88.79%) |
NFKBIA;AHR;IL6ST;...
|
| Antigen processing and presentation |
2.03 |
0.00e+0 |
60/78 (76.92%) |
HSPA1A;HSPA6;HLA-DRB1;...
|
| Asthma |
2.00 |
0.00e+0 |
25/31 (80.65%) |
HLA-DRB1;HLA-DRA;HLA-DQB1;...
|
| TNF signaling pathway |
1.98 |
0.00e+0 |
103/112 (91.96%) |
CXCL2;TNFAIP3;NFKBIA;...
|
| Inflammatory bowel disease |
1.98 |
0.00e+0 |
58/65 (89.23%) |
NFKB1;HLA-DRB1;IFNGR1;...
|
| Autoimmune thyroid disease |
1.97 |
0.00e+0 |
46/53 (86.79%) |
HLA-DRB1;HLA-DRA;HLA-B;...
|
| Rheumatoid arthritis |
1.97 |
0.00e+0 |
78/93 (83.87%) |
CXCL8;CXCL2;HLA-DRB1;...
|
| Longevity regulating pathway |
1.94 |
0.00e+0 |
90/151 (59.6%) |
HSPA1A;CRYAB;HSPA6;...
|
| Lipid and atherosclerosis |
1.93 |
0.00e+0 |
190/215 (88.37%) |
HSPA1A;CXCL8;CXCL2;...
|
| IL-17 signaling pathway |
1.92 |
0.00e+0 |
84/94 (89.36%) |
CXCL8;CXCL2;TNFAIP3;...
|
| Leishmaniasis |
1.90 |
0.00e+0 |
67/77 (87.01%) |
NFKBIA;CYBA;NFKB1;...
|
| Ferroptosis |
1.87 |
6.40e-4 |
36/41 (87.8%) |
SAT1;SLC39A8;SLC7A11;...
|
| JAK-STAT signaling pathway |
1.87 |
6.05e-4 |
146/162 (90.12%) |
MYC;MCL1;CSF2RB;...
|
| Phagosome |
1.86 |
1.72e-3 |
118/152 (77.63%) |
CYBA;COMP;ACTB;...
|
| Th1 and Th2 cell differentiation |
1.86 |
2.18e-3 |
80/92 (86.96%) |
NFKBIA;JAG1;NFKB1;...
|
| Type I diabetes mellitus |
1.82 |
3.63e-3 |
38/43 (88.37%) |
HLA-DRB1;HLA-DRA;HLA-B;...
|
| Kaposi sarcoma-associated herpesvirus infection |
1.82 |
3.46e-3 |
172/193 (89.12%) |
CXCL8;CXCL2;MYC;...
|
| Cytokine-cytokine receptor interaction |
1.80 |
5.21e-3 |
246/295 (83.39%) |
CXCL8;CXCL2;CSF2RB;...
|
| Protein processing in endoplasmic reticulum |
1.74 |
1.45e-2 |
127/171 (74.27%) |
HERPUD1;HSPA1A;CRYAB;...
|
| Circadian rhythm |
1.73 |
1.39e-2 |
26/31 (83.87%) |
BHLHE40;PER1;PRKAA1;...
|
| Fluid shear stress and atherosclerosis |
1.72 |
1.51e-2 |
123/139 (88.49%) |
CYBA;ARHGEF2;ACTB;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
1.72 |
1.53e-2 |
62/70 (88.57%) |
CXCL8;CXCL2;NFKBIA;...
|
| Osteoclast differentiation |
1.72 |
1.56e-2 |
117/127 (92.13%) |
FHL2;RELB;FOSB;...
|
| Salmonella infection |
1.70 |
1.69e-2 |
198/249 (79.52%) |
CXCL8;MYC;NFKBIA;...
|
| Chronic myeloid leukemia |
1.70 |
1.63e-2 |
72/76 (94.74%) |
MYC;NFKBIA;NRAS;...
|
| Mineral absorption |
-1.93 |
2.63e-2 |
48/60 (80%) |
SLC26A6;ATP1B1;HMOX2;...
|
